Subjective  ||| S:0 E:11 ||| NNP
and  ||| S:11 E:15 ||| CC
perceptual  ||| S:15 E:26 ||| JJ
analysis  ||| S:26 E:35 ||| NN
of  ||| S:35 E:38 ||| IN
voice  ||| S:38 E:44 ||| NN
quality  ||| S:44 E:52 ||| NN
and  ||| S:52 E:56 ||| CC
relationship  ||| S:56 E:69 ||| NN
with  ||| S:69 E:74 ||| IN
neurological  ||| S:74 E:87 ||| JJ
disfunction  ||| S:87 E:99 ||| NN
in  ||| S:99 E:102 ||| IN
multiple  ||| S:102 E:111 ||| JJ
sclerosis  ||| S:111 E:121 ||| NN
patients  ||| S:121 E:130 ||| NNS
The  ||| S:130 E:134 ||| DT
aim  ||| S:134 E:138 ||| NN
of  ||| S:138 E:141 ||| IN
the  ||| S:141 E:145 ||| DT
present  ||| S:145 E:153 ||| JJ
study  ||| S:153 E:159 ||| NN
was  ||| S:159 E:163 ||| VBD
to  ||| S:163 E:166 ||| TO
evaluate  ||| S:166 E:175 ||| VB
subjective  ||| S:175 E:186 ||| JJ
voice  ||| S:186 E:192 ||| NN
changes  ||| S:192 E:200 ||| NNS
by  ||| S:200 E:203 ||| IN
voice  ||| S:203 E:209 ||| NN
handicap  ||| S:209 E:218 ||| NN
index  ||| S:218 E:224 ||| NN
( ||| S:224 E:225 ||| -LRB-
VHI ||| S:225 E:228 ||| NNP
)  ||| S:228 E:230 ||| -RRB-
and  ||| S:230 E:234 ||| CC
voice  ||| S:234 E:240 ||| NN
related  ||| S:240 E:248 ||| VBN
quality  ||| S:248 E:256 ||| NN
of  ||| S:256 E:259 ||| IN
life  ||| S:259 E:264 ||| NN
questionnaire  ||| S:264 E:278 ||| NN
( ||| S:278 E:279 ||| -LRB-
VRQL ||| S:279 E:283 ||| NNP
)  ||| S:283 E:285 ||| -RRB-
and  ||| S:285 E:289 ||| CC
perceptual  ||| S:289 E:300 ||| JJ
voice  ||| S:300 E:306 ||| NN
changes  ||| S:306 E:314 ||| NNS
by  ||| S:314 E:317 ||| IN
Grade  ||| S:317 E:323 ||| NNP
Roughness  ||| S:323 E:333 ||| NNP
Breathiness  ||| S:333 E:345 ||| NNP
Asthenia  ||| S:345 E:354 ||| NNP
Strain  ||| S:354 E:361 ||| NNP
( ||| S:361 E:362 ||| -LRB-
GRBAS ||| S:362 E:367 ||| NNP
)  ||| S:367 E:369 ||| -RRB-
scale  ||| S:369 E:375 ||| NN
and  ||| S:375 E:379 ||| CC
to  ||| S:379 E:382 ||| TO
compare  ||| S:382 E:390 ||| VB
these  ||| S:390 E:396 ||| DT
findings  ||| S:396 E:405 ||| NNS
with  ||| S:405 E:410 ||| IN
expanded  ||| S:410 E:419 ||| JJ
disability  ||| S:419 E:430 ||| NN
status  ||| S:430 E:437 ||| NN
scale  ||| S:437 E:443 ||| NN
( ||| S:443 E:444 ||| -LRB-
EDSS ||| S:444 E:448 ||| NNP
)  ||| S:448 E:450 ||| -RRB-
in  ||| S:450 E:453 ||| IN
multiple  ||| S:453 E:462 ||| JJ
sclerosis  ||| S:462 E:472 ||| NNS
( ||| S:472 E:473 ||| -LRB-
MS ||| S:473 E:475 ||| NNP
)  ||| S:475 E:477 ||| -RRB-
patients ||| S:477 E:485 ||| NNS
.  ||| S:485 E:487 ||| .
The  ||| S:487 E:491 ||| DT
patient  ||| S:491 E:499 ||| JJ
group  ||| S:499 E:505 ||| NN
was  ||| S:505 E:509 ||| VBD
composed  ||| S:509 E:518 ||| VBN
of  ||| S:518 E:521 ||| IN
36  ||| S:521 E:524 ||| CD
MS  ||| S:524 E:527 ||| NN
patients ||| S:527 E:535 ||| NNS
,  ||| S:535 E:537 ||| ,
( ||| S:537 E:538 ||| -LRB-
mean  ||| S:538 E:543 ||| JJ
age  ||| S:543 E:547 ||| NN
45.2  ||| S:547 E:552 ||| CD
±  ||| S:552 E:554 ||| CD
12.9 ||| S:554 E:558 ||| CD
,  ||| S:558 E:560 ||| ,
13  ||| S:560 E:563 ||| CD
male  ||| S:563 E:568 ||| NN
and  ||| S:568 E:572 ||| CC
23  ||| S:572 E:575 ||| CD
female ||| S:575 E:581 ||| NN
)  ||| S:581 E:583 ||| -RRB-
and  ||| S:583 E:587 ||| CC
compared  ||| S:587 E:596 ||| VBN
with  ||| S:596 E:601 ||| IN
32  ||| S:601 E:604 ||| CD
healthy  ||| S:604 E:612 ||| JJ
sex  ||| S:612 E:616 ||| NN
and  ||| S:616 E:620 ||| CC
age  ||| S:620 E:624 ||| NN
match  ||| S:624 E:630 ||| NN
individuals  ||| S:630 E:642 ||| NNS
without  ||| S:642 E:650 ||| IN
neurological  ||| S:650 E:663 ||| NN
and  ||| S:663 E:667 ||| CC
voice  ||| S:667 E:673 ||| NN
symptoms ||| S:673 E:681 ||| NNS
.  ||| S:681 E:683 ||| .
The  ||| S:683 E:687 ||| DT
mean  ||| S:687 E:692 ||| JJ
VHI  ||| S:692 E:696 ||| NNP
was  ||| S:696 E:700 ||| VBD
significantly  ||| S:700 E:714 ||| RB
higher  ||| S:714 E:721 ||| JJR
in  ||| S:721 E:724 ||| IN
patients  ||| S:724 E:733 ||| NNS
group  ||| S:733 E:739 ||| NN
( ||| S:739 E:740 ||| -LRB-
15.64  ||| S:740 E:746 ||| CD
to  ||| S:746 E:749 ||| TO
5.43 ||| S:749 E:753 ||| CD
;  ||| S:753 E:755 ||| :
p=0.043 ||| S:755 E:762 ||| CD
) ||| S:762 E:763 ||| -RRB-
.  ||| S:763 E:765 ||| .
Forty-four  ||| S:765 E:776 ||| JJ
percent  ||| S:776 E:784 ||| NN
of  ||| S:784 E:787 ||| IN
MS  ||| S:787 E:790 ||| NNP
patients  ||| S:790 E:799 ||| NNS
( ||| S:799 E:800 ||| -LRB-
52 ||| S:800 E:802 ||| CD
%  ||| S:802 E:804 ||| NN
of  ||| S:804 E:807 ||| IN
female  ||| S:807 E:814 ||| JJ
patients ||| S:814 E:822 ||| NNS
)  ||| S:822 E:824 ||| -RRB-
report  ||| S:824 E:831 ||| NN
voice  ||| S:831 E:837 ||| NN
problems ||| S:837 E:845 ||| NNS
.  ||| S:845 E:847 ||| .
According  ||| S:847 E:857 ||| VBG
to  ||| S:857 E:860 ||| TO
the  ||| S:860 E:864 ||| DT
GRBAS  ||| S:864 E:870 ||| NNP
scale ||| S:870 E:875 ||| NN
,  ||| S:875 E:877 ||| ,
differences  ||| S:877 E:889 ||| NNS
between  ||| S:889 E:897 ||| IN
two  ||| S:897 E:901 ||| CD
groups  ||| S:901 E:908 ||| NNS
were  ||| S:908 E:913 ||| VBD
significant  ||| S:913 E:925 ||| JJ
for  ||| S:925 E:929 ||| IN
Grade ||| S:929 E:934 ||| NNP
,  ||| S:934 E:936 ||| ,
Roughness ||| S:936 E:945 ||| NNP
,  ||| S:945 E:947 ||| ,
Breathiness  ||| S:947 E:959 ||| NNP
and  ||| S:959 E:963 ||| CC
Strain  ||| S:963 E:970 ||| NNP
items ||| S:970 E:975 ||| NNS
.  ||| S:975 E:977 ||| .
The  ||| S:977 E:981 ||| DT
mean  ||| S:981 E:986 ||| JJ
EDSS  ||| S:986 E:991 ||| NNP
was  ||| S:991 E:995 ||| VBD
2.69  ||| S:995 E:1000 ||| CD
±  ||| S:1000 E:1002 ||| CD
1.1 ||| S:1002 E:1005 ||| CD
,  ||| S:1005 E:1007 ||| ,
for  ||| S:1007 E:1011 ||| IN
a  ||| S:1011 E:1013 ||| DT
male  ||| S:1013 E:1018 ||| JJ
patients  ||| S:1018 E:1027 ||| NNS
2.54  ||| S:1027 E:1032 ||| CD
±  ||| S:1032 E:1034 ||| CD
1.1  ||| S:1034 E:1038 ||| CD
and  ||| S:1038 E:1042 ||| CC
for  ||| S:1042 E:1046 ||| IN
female  ||| S:1046 E:1053 ||| JJ
2.78  ||| S:1053 E:1058 ||| CD
±  ||| S:1058 E:1060 ||| CD
1.3 ||| S:1060 E:1063 ||| CD
.  ||| S:1063 E:1065 ||| .
There  ||| S:1065 E:1071 ||| EX
was  ||| S:1071 E:1075 ||| VBD
no  ||| S:1075 E:1078 ||| DT
correlation  ||| S:1078 E:1090 ||| NN
between  ||| S:1090 E:1098 ||| IN
the  ||| S:1098 E:1102 ||| DT
EDSS  ||| S:1102 E:1107 ||| NNP
and  ||| S:1107 E:1111 ||| CC
the  ||| S:1111 E:1115 ||| DT
total  ||| S:1115 E:1121 ||| JJ
VHI  ||| S:1121 E:1125 ||| NNP
score ||| S:1125 E:1130 ||| NN
,  ||| S:1130 E:1132 ||| ,
between  ||| S:1132 E:1140 ||| IN
the  ||| S:1140 E:1144 ||| DT
EDSS  ||| S:1144 E:1149 ||| NNP
and  ||| S:1149 E:1153 ||| CC
each  ||| S:1153 E:1158 ||| DT
of  ||| S:1158 E:1161 ||| IN
the  ||| S:1161 E:1165 ||| DT
three  ||| S:1165 E:1171 ||| CD
item  ||| S:1171 E:1176 ||| NN
of  ||| S:1176 E:1179 ||| IN
VHI ||| S:1179 E:1182 ||| NNP
,  ||| S:1182 E:1184 ||| ,
between  ||| S:1184 E:1192 ||| IN
the  ||| S:1192 E:1196 ||| DT
EDSS  ||| S:1196 E:1201 ||| NNP
and  ||| S:1201 E:1205 ||| CC
VRQL ||| S:1205 E:1209 ||| NNP
,  ||| S:1209 E:1211 ||| ,
nor  ||| S:1211 E:1215 ||| CC
between  ||| S:1215 E:1223 ||| IN
the  ||| S:1223 E:1227 ||| DT
EDSS  ||| S:1227 E:1232 ||| NNP
and  ||| S:1232 E:1236 ||| CC
components  ||| S:1236 E:1247 ||| NNS
of  ||| S:1247 E:1250 ||| IN
GRBAS  ||| S:1250 E:1256 ||| NNP
scale  ||| S:1256 E:1262 ||| NN
except  ||| S:1262 E:1269 ||| IN
for  ||| S:1269 E:1273 ||| IN
EDSS  ||| S:1273 E:1278 ||| NNP
and  ||| S:1278 E:1282 ||| CC
asthenia  ||| S:1282 E:1291 ||| JJ
item ||| S:1291 E:1295 ||| NN
,  ||| S:1295 E:1297 ||| ,
( ||| S:1297 E:1298 ||| -LRB-
r=-0.5213 ||| S:1298 E:1307 ||| NNP
,  ||| S:1307 E:1309 ||| ,
p=0.011 ||| S:1309 E:1316 ||| CD
) ||| S:1316 E:1317 ||| -RRB-
.  ||| S:1317 E:1319 ||| .
Significant  ||| S:1319 E:1331 ||| JJ
number  ||| S:1331 E:1338 ||| NN
of  ||| S:1338 E:1341 ||| IN
MS  ||| S:1341 E:1344 ||| NNP
patients  ||| S:1344 E:1353 ||| NNS
experienced  ||| S:1353 E:1365 ||| JJ
voice  ||| S:1365 E:1371 ||| NN
problems ||| S:1371 E:1379 ||| NNS
.  ||| S:1379 E:1381 ||| .
We  ||| S:1381 E:1384 ||| PRP
did  ||| S:1384 E:1388 ||| VBD
not  ||| S:1388 E:1392 ||| RB
establish  ||| S:1392 E:1402 ||| VB
any  ||| S:1402 E:1406 ||| DT
significant  ||| S:1406 E:1418 ||| JJ
correlation  ||| S:1418 E:1430 ||| NN
between  ||| S:1430 E:1438 ||| IN
the  ||| S:1438 E:1442 ||| DT
intensity  ||| S:1442 E:1452 ||| NN
of  ||| S:1452 E:1455 ||| IN
the  ||| S:1455 E:1459 ||| DT
voice  ||| S:1459 E:1465 ||| NN
disorders  ||| S:1465 E:1475 ||| NNS
and  ||| S:1475 E:1479 ||| CC
EDSS ||| S:1479 E:1483 ||| NNP
,  ||| S:1483 E:1485 ||| ,
except  ||| S:1485 E:1492 ||| IN
between  ||| S:1492 E:1500 ||| IN
EDSS  ||| S:1500 E:1505 ||| NNP
and  ||| S:1505 E:1509 ||| CC
asthenia  ||| S:1509 E:1518 ||| JJ
item  ||| S:1518 E:1523 ||| NN
of  ||| S:1523 E:1526 ||| IN
the  ||| S:1526 E:1530 ||| DT
GRBAS  ||| S:1530 E:1536 ||| NNP
scale ||| S:1536 E:1541 ||| NN
.  ||| S:1541 E:1543 ||| .
The  ||| S:1543 E:1547 ||| DT
patients  ||| S:1547 E:1556 ||| NNS
with  ||| S:1556 E:1561 ||| IN
low  ||| S:1561 E:1565 ||| JJ
EDSS  ||| S:1565 E:1570 ||| NNP
may  ||| S:1570 E:1574 ||| MD
have  ||| S:1574 E:1579 ||| VB
serious  ||| S:1579 E:1587 ||| JJ
voice  ||| S:1587 E:1593 ||| NN
problems  ||| S:1593 E:1602 ||| NNS
and  ||| S:1602 E:1606 ||| CC
vice  ||| S:1606 E:1611 ||| FW
versa ||| S:1611 E:1616 ||| FW
.  ||| S:1616 E:1618 ||| .
